AI-generated summary
The authors randomized participants with long-term taste impairment after COVID-19 to photobiomodulation, transmucosal laser irradiation of blood, B complex supplementation, or sham laser. No statistically significant differences between groups were found at the final evaluation, although the authors note tendencies toward better results with photobiomodulation and transmucosal laser irradiation. The authors suggest these may be options, but full recovery of taste and smell was not achieved.
- Who or what was studied
- Adults with COVID-19 related long-term taste impairment lasting at least 2 months, confirmed by PCR-RT testing
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- No intergroup differences were statistically significant, and total remission of taste and smell was not achieved.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.